Synonyms
Autoimmune disease and hair loss
Definition
Hair loss that is directly associated with autoimmune disease involves immune mechanisms in its pathogenesis targeting the hair follicles. They may be localized or generalized, as well as scarring and non-scarring in type. Secondary factors may also play a role in hair growth, including the medications used to treat the primary disease.
Lupus
Hair loss is one of the most common cutaneous signs of systemic lupus erythematosus (SLE) and is present in more than half the patients at some time during the course of their illness (Moghadam-Kia and Franks 2013). Alopecia can be the presenting manifestation of SLE and may affect the scalp, eyebrows, eyelashes, beard hair, or body hair (McCauliffe and Sontheimer 1996). Alopecia may be associated with active disease and can also occur due to immunosuppressive medications used to treat lupus. Lupus alopecia can be scarring associated with discoid lupus or non-scarring. The Systemic Lupus...
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alarcon-Segovia D, Cetina JA. Lupus hair. Am J Med Sci. 1974;267(4):241–2.
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010a;62(2):177–88.
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II. Treatment. J Am Acad Dermatol. 2010b;62(2):191–202.
Borovicka JH, Thomas L, Prince C, Mehregan DR. Scarring alopecia: clinical and pathologic study of 54 African-American women. Int J Dermatol. 2009;48(8):840–5.
Callen JP. Dermatomyositis. Lancet. 2000;355(9197):53–7.
Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol. 2006;24(5):363–73.
Chung L, Lin J, Furst DE, Fiorentino D. Systemic and localized scleroderma. Clin Dermatol. 2006;24(5):374–92.
Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, Kyttaris VC, Juang YT, Tsokos GC. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761–6.
Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971–82.
Dawkins MA, Jorizzo JL, Walker FO, Albertson D, Sinal SH, Hinds A. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol. 1998;38(3):397–404.
Donnelly AM, Halbert AR, Rohr JB. Discoid lupus erythematosus. Australas J Dermatol. 1995;36(1):3–10; quiz 11–2. Review.
Dourmishev LA, Wollina U. Dermatomyositis: immunopathologic study of skin lesions. Acta Dermatovenerol Alp Panonica Adriat. 2006;15(1):45–51.
Dutz JP, Sontheimer RD. Pathomechanisms of cutaneous lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubos’ Lupus erythematosus. 6th ed. Philadelphia: Lippincot William & Wilkins; 2002. p. 549–71.
Euwer RL, Sonthheimer RD. Dermatomyositis. In: Sontheimer RD, Provost TT, editors. Cutaneous manifestations of rheumatic disease. Baltimore: Williams and Wilkins; 1996. p. 73.
Fabbri P, Amato L, Chiarini C, Moretti S, Massi D. Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study. Lupus. 2004;13(6):455–62.
Ferraz LB, Almeida FA, Vasconcellos MR, Faccina AS, Ciconelli RM, Ferraz MB. The impact of lupus erythematosus cutaneous on the Quality of life: the Brazilian-Portuguese version of DLQI. Qual Life Res. 2006;15(3):565–70.
Gilliam AC. Scleroderma. Curr Dir Autoimmun. 2008;10:258–79.
Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471–5.
Gilliam JN, Sontheimer RD. Skin manifestations of SLE. Clin Rheum Dis. 1982;8(1):207–18.
Kasteler JS, Callen JP. Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed. JAMA. 1994;272(24):1939–41.
McCauliffe DP, Sontheimer RD. Cutaneous lupus erythematosus. In: Schur PH, editor. The clinical management of systemic lupus erythematosus. Secondth ed. Philadelphia: Lippincott; 1996.
Moghadam-Kia S, Franks Jr AG. Autoimmune disease and hair loss. Dermatol Clin. 2013;31(1):75–91.
Moises-Alfaro C, Berrón-Pérez R, Carrasco-Daza D, Gutiérrez-Castrellón P, Ruiz-Maldonado R. Discoid lupus erythematosus in children: clinical, histopathologic, and follow-up features in 27 cases. Pediatr Dermatol. 2003;20(2):103–7.
Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and femalepattern hair loss. J Am Acad Dermatol. 2005;52(2):301–11.
Petri M, Orbai A, Alarcón G, et al. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.
Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias. J Am Acad Dermatol. 2005;53(1):1–37; quiz 38–40. Review. Erratum in: J Am Acad Dermatol. 2005;53(3):496.
Santmyire-Rosenberger B, Dugan EM. Skin involvement in dermatomyositis. Curr Opin Rheumatol. 2003;15(6):714–22.
Sellheyer K, Bergfeld WF. Histopathologic evaluation of alopecias. Am J Dermatopathol. 2006;28(3):236–59.
Shapiro J. Cicatricial (scarring) alopecias. In: Shapiro J, editor. Hair loss: principles of diagnosis and management of alopecia. London: Martin Duniz; 2002. p. 155–74.
Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998;317(7162):865–9.
Sontheimer RD, McCauliffe DP. Cutaneous manifestations of lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubos’ lupus erythematosus. 6th ed. Philadelphia: Lippincot William & Wilkins; 2002. p. 573–618.
Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol. 2004;50(1):25–32.
Tanasescu C, Balanescu E, Balanescu P, Olteanu R, Badea C, Grancea C, Vagu C, Bleotu C, Ardeleanu C, Georgescu A. IL-17 in cutaneous lupus erythematosus. Eur J Intern Med. 2010;21(3):202–7.
Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin. 2007;25(2):223–31.
Tymms KE, Webb J. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol. 1985;12(6):1140–8.
Werth VP, White WL, Sanchez MR, Franks AG. Incidence of alopecia areata in lupus erythematosus. Arch Dermatol. 1992;128(3):368–71.
Whiting DA. Cicatricial alopecia: clinico-pathological findings and treatment. Clin Dermatol. 2001;19(2):211–25.
Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol. 1996;135(3):355–62.
Zhang Z, Kyttaris VC, Tsokos GC. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol. 2009;183(5):3160–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Moghadam-Kia, S., Franks, A.G. (2014). Alopecia in Systemic Autoimmune Disease. In: Mackay, I.R., Rose, N.R., Diamond, B., Davidson, A. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84828-0_232
Download citation
DOI: https://doi.org/10.1007/978-0-387-84828-0_232
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84827-3
Online ISBN: 978-0-387-84828-0
eBook Packages: MedicineReference Module Medicine